TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2026)
TELA Bio (TELA) posted quarterly Total Non-Current Liabilities of $73.7 million for Q1 2026, up 27.48% year-over-year from $57.8 million in Q1 2025, and little changed quarter-over-quarter from $73.6 million in Q4 2025.
TELA Bio (TELA) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
TELA Bio's Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $73.7 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 27.48% year-over-year to $73.7 million; the TTM figure through Mar 2026 stood at $73.7 million (up 27.48% YoY), while the FY2025 annual figure was $73.6 million, up 29.81% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $73.7 million, roughly flat from $73.6 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $73.7 million in Q1 2026, with the low at $44.0 million in Q1 2022.
- The 5-year median for Total Non-Current Liabilities is $55.8 million (2024), against an average of $57.1 million.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities jumped 35.11% in 2022, then decreased 1.32% in 2024.
- TELA Bio's Total Non-Current Liabilities stood at $52.3 million in 2022, then advanced by 9.87% to $57.5 million in 2023, then fell by 1.32% to $56.7 million in 2024, then rose by 29.81% to $73.6 million in 2025, then grew by 0.1% to $73.7 million in 2026.
- Business Quant data shows TELA's Total Non-Current Liabilities at $73.7 million in Q1 2026, $73.6 million in Q4 2025, and $58.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 3.44 Bn |
| 10 | TELA Bio | 37.86 Mn | 7.44 Mn | 13.94 Mn | 74.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.30 Mn |
| Mar 31, 2026 | 73.70 Mn |
| Dec 31, 2025 | 73.63 Mn |
| Sep 30, 2025 | 58.47 Mn |
| Jun 30, 2025 | 57.11 Mn |
| Mar 31, 2025 | 57.81 Mn |
| Dec 31, 2024 | 56.72 Mn |
| Sep 30, 2024 | 57.83 Mn |
| Jun 30, 2024 | 55.81 Mn |
| Mar 31, 2024 | 55.84 Mn |
| Dec 31, 2023 | 57.48 Mn |
| Sep 30, 2023 | 55.70 Mn |
| Jun 30, 2023 | 53.26 Mn |
| Mar 31, 2023 | 54.47 Mn |
| Dec 31, 2022 | 52.32 Mn |
| Sep 30, 2022 | 54.98 Mn |
| Jun 30, 2022 | 51.54 Mn |
| Mar 31, 2022 | 43.96 Mn |
| Dec 31, 2021 | 42.07 Mn |
| Sep 30, 2021 | 40.69 Mn |